Literature DB >> 19758443

E box motifs as mediators of proviral latency of human retroviruses.

Jean-Michel Terme1, Sébastien Calvignac, Madeleine Duc Dodon, Louis Gazzolo, Albert Jordan.   

Abstract

The palindromic sequence motifs (CANNTG) known as E boxes are considered as binding sites for the basic helix-loop-helix (bHLH) class of DNA-binding proteins. Their presence has been reported in the long terminal repeats (LTR) of the HIV-1 and HTLV-1 proviruses. Their close proximity with the TATA region of both LTRs indicates that the bHLH proteins may act as important regulators of the function of proviral transcription. Indeed, observations on HIV-1 and recent results on HTLV-1 underline that these E boxes may be critically involved in the regulation of the proviral transcription of these human retroviruses. Indeed, of the two E boxes flanking the TATA sequences of the HIV-1 provirus, the 3' E box has been implicated in the transcriptional inhibition of viral gene expression. Such a role might also be played by the unique 5' E box present in the HTLV-1 LTR. In both cases, the expression of tissue-specfic bHLH proteins, like TAL1 might counteract the inhibitory effect exerted by E box proteins, thereby increasing proviral transcription. Finally, a phylogenetic study encompassing several subtypes of these two human retroviruses underlines that these E box motifs have recently appeared in the proviral LTRs and may be considered as potential mediators in the establishment of proviral latency.

Entities:  

Mesh:

Year:  2009        PMID: 19758443      PMCID: PMC2749803          DOI: 10.1186/1742-4690-6-81

Source DB:  PubMed          Journal:  Retrovirology        ISSN: 1742-4690            Impact factor:   4.602


  28 in total

1.  Generation of HIV latency during thymopoiesis.

Authors:  D G Brooks; S G Kitchen; C M Kitchen; D D Scripture-Adams; J A Zack
Journal:  Nat Med       Date:  2001-04       Impact factor: 53.440

Review 2.  Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms.

Authors:  M E Massari; C Murre
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

3.  Interactions of HTF4 with E-box motifs in the long terminal repeat of human immunodeficiency virus type 1.

Authors:  Y Zhang; K Doyle; M Bina
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

Review 4.  E and ID proteins branch out.

Authors:  Barbara L Kee
Journal:  Nat Rev Immunol       Date:  2009-03       Impact factor: 53.106

5.  Evolution of human immunodeficiency virus type 1 nef and long terminal repeat sequences over 4 years in vivo and in vitro.

Authors:  S Delassus; R Cheynier; S Wain-Hobson
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

6.  Human immunodeficiency virus type 1 long terminal repeat variants from 42 patients representing all stages of infection display a wide range of sequence polymorphism and transcription activity.

Authors:  M C Estable; B Bell; A Merzouki; J S Montaner; M V O'Shaughnessy; I J Sadowski
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

7.  Absence of selection of HIV-1 variants in vivo based on transcription/transactivation during progression to AIDS.

Authors:  S Delassus; A Meyerhans; R Cheynier; S Wain-Hobson
Journal:  Virology       Date:  1992-06       Impact factor: 3.616

8.  Distinguishable patterns of protein-DNA interactions involving complexes of basic helix-loop-helix proteins.

Authors:  K Doyle; Y Zhang; R Baer; M Bina
Journal:  J Biol Chem       Date:  1994-04-22       Impact factor: 5.157

9.  TAL1/SCL induces leukemia by inhibiting the transcriptional activity of E47/HEB.

Authors:  Jennifer O'Neil; Jennifer Shank; Nicole Cusson; Cornelis Murre; Michelle Kelliher
Journal:  Cancer Cell       Date:  2004-06       Impact factor: 31.743

10.  Role of flanking E box motifs in human immunodeficiency virus type 1 TATA element function.

Authors:  S H Ou; L F Garcia-Martínez; E J Paulssen; R B Gaynor
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

View more
  5 in total

1.  Epigenetic analysis of HIV-1 proviral genomes from infected individuals: predominance of unmethylated CpG's.

Authors:  Stefanie Weber; Barbara Weiser; Kimdar S Kemal; Harold Burger; Christina M Ramirez; Klaus Korn; Kathryn Anastos; Rupert Kaul; Colin Kovacs; Walter Doerfler
Journal:  Virology       Date:  2013-12-05       Impact factor: 3.616

2.  Distinctive variation in the U3R region of the 5' Long Terminal Repeat from diverse HIV-1 strains.

Authors:  Christelle Mbondji-Wonje; Ming Dong; Xue Wang; Jiangqin Zhao; Viswanath Ragupathy; Ana M Sanchez; Thomas N Denny; Indira Hewlett
Journal:  PLoS One       Date:  2018-04-17       Impact factor: 3.240

3.  Genetic Evolution during the development of an attenuated EIAV vaccine.

Authors:  Xue-Feng Wang; Yue-Zhi Lin; Qiang Li; Qiang Liu; Wei-Wei Zhao; Cheng Du; Jie Chen; Xiaojun Wang; Jian-Hua Zhou
Journal:  Retrovirology       Date:  2016-02-03       Impact factor: 4.602

Review 4.  Regulation of Expression and Latency in BLV and HTLV.

Authors:  Aneta Pluta; Juan P Jaworski; Renée N Douville
Journal:  Viruses       Date:  2020-09-25       Impact factor: 5.048

5.  Genetic variability of the U5 and downstream sequence of major HIV-1 subtypes and circulating recombinant forms.

Authors:  Christelle Mbondji-Wonje; Ming Dong; Jiangqin Zhao; Xue Wang; Aubin Nanfack; Viswanath Ragupathy; Ana M Sanchez; Thomas N Denny; Indira Hewlett
Journal:  Sci Rep       Date:  2020-08-06       Impact factor: 4.996

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.